glp-1 ileus class action in michigan legal team GLP-1 receptor agonism: a transformative approach for managing type-2 diabetes and obesity glp-1 ileus class action in

Effectiveness and safety of glucagon-like peptide-1 receptor agonist in a cohort of kidney transplant recipients

Oral vitamins can be used to maintain the effect for longer time period

The VA data here is exactly what we keep seeing in real-world clinical practice: when patients with obesity get access to GLP-1 therapy and stick with it, the downstream metabolic and cardiovascular improvements are substantial and consistent

Psychiatry 118:110580

Conversely, discontinuation rates were increased to 33.7% (95% CI 33.4, 34.0) at 1 year and 50.6% (95% CI 50.3, 50.9) at 3 years when using a grace period of 60 days (ESM Table 4)